Summary
The release of prostacyclin and PGE2 from the isolated perfused hearts of acutely diabetic (streptozotocin 100 mg/kg) rats was studied and compared with hearts from control animals. Prostacyclin and PGE2 were measured by a differential bioassay technique. No basal release of either prostaglandin was detected. However, after addition of arachidonic acid, a dose dependent release of prostacyclin and PGE2 was noted. Prostacyclin was identified as the major prostaglandin. Release of prostacyclin and PGE2 from acutely diabetic rat hearts was increased 2–3 times compared to control hearts. No release of prostaglandin endoperoxides was observed in either group of hearts.
Article PDF
Similar content being viewed by others
References
Brownlee M, Cahill GF (1979) Diabetic control and vascular complications. In: Paoletti R (ed) Atherosclerosis reviews, vol 4. Raven Press, New York, p 29–70
Colwell JA, Chambers A, Laimins M (1975) Increased platelet aggregation in early diabetes. Diabetes 24: 684–687
Fraser R, Lowy C, Elkeles RS, Lewis B, Mancini M (1973) Insulin, glucose and lipid levels in mild diabetes in regulation to complications. In: Camerini-Davalos RA, Cole HS (eds) Vascular and neurological changes in early diabetes. Academic Press, New York, p 83–93
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 74: 2994–2998
Ellis E, Oelz O, Roberts J, Payne N, Oates J (1976) Coronary arterial smooth muscle contracted by a substance released by platelets: evidence that it is thromboxane A2. Science 193: 638–643
Moncada S, Vane JR (1977) The discovery of prostacyclin (PGX). A fresh insight into arachidonic acid metabolism. In: Kharasch N, Fried J (eds) Interscience Prostaglandin Symposium. Academic Press, New York San Francisco London, p 155–177
Moncada S, Vane JR (1979) Arachidonic acid metabolism and the interactions between platelets and blood vessel wall. N Engl J Med 300: 1142–1147
Stam H, Hülsmann WC (1977) Effect of fasting and streptozotocin-diabetes on the coronary flow in isolated rat hearts: a possible role of endogenous catecholamines and prostaglandins. Basic Res Cardiol 72: 365–375
De Deckere EAM, Nugteren DH, Ten Hoor T (1977) Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart. Nature 268: 160–163
Dusting GJ, Moncada S, Vane JR (1977) Prostacyclin is an endogenous metabolite of arachidonic acid which relaxes coronary arteries. Prostaglandins 13: 3–15
Vane JR (1969) The release and fate of vasoactive hormones in the circulation. Br J Pharmacol 35: 209–242
Block AJ, Feinberg H, Herbaczynska-Cedro K, Vane JR (1975) Anoxia-induced release of prostaglandins in rabbit isolated hearts. Circ Res 36: 34–42
Schrör K, Moncada S, Ubatuba FB, Vane JR (1978) Transformation of arachidonic acid and prostaglandin endoperoxides by guinea-pig heart. Formation of RCS and prostacyclin (PGX) Eur J Pharmacol 47: 103–114
Schrör K, Moncada S, Ubatuba FB, Vane JR (1977) Formation of prostacyclin (PGX) causes decrease in the coronary vascular resistance during application of arachidonic acid. Naunyn Schmiedebergs Arch Pharmacol 297: R 31
Eldor A, Merin S, Bar-On H (1978) The effect of streptozotocin diabetes on platelet function in rats. Thromb Res 13: 703–714
Harrison HE, Reece AH, Johnson M (1978) Decreased vascular prostacyclin in experimental diabetes. Diabetologia 14: 237
Gryglewski RJ, Dembinska-Kiec A, Zmuda A, Gryglewska T (1978) Prostacyclin and thromboxane A2 biosynthetic capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 31: 385–394
Bohlen HG, Niggl BA (1979) Arteriolar anatomical and functional abnormalities in juvenile mice with genetic or streptozotocin-induced diabetes mellitus. Circ Res 45: 390–396
Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissues generate prostacyclin, a potent inhibitor of platelet aggregation. Lancet I: 18–20
Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H (1979) Decreased vascular prostacyclin in juvenile onset diabetics. N Engl J Med 300: 366–367
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rösen, P., Schrör, K. Increased prostacyclin release from perfused hearts of acutely diabetic rats. Diabetologia 18, 391–394 (1980). https://doi.org/10.1007/BF00276820
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00276820